Phenyl-methylene hydantoins alter CD44-specific ligand binding of benign and malignant prostate cells and suppress CD44 isoform expression.
Kui Yang(First Affiliated Hospital of Xi'an Jiaotong University), Kenneth A. Iczkowski(University of California, Davis), Yaqiong Tang(Soochow University)
PubMed
January 1, 2010
Cited by 12
Related Papers
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
|The Lancet Oncology|2020|631
Cell-Free DNA in Human Blood Plasma
|Pancreas|1998|381
Bacteriophages show promise as antimicrobial agents
|Journal of Infection|1998|319